Aarey Drugs & Pharmaceuticals Ltd — Quarterly Results & Earnings

₹50.75

-9.78%

Profit Growth YoY-36.25%Latest quarter

Sales Growth YoY-19.95%Latest quarter

Sales CAGR 5Y9.76%5 year compound

Profit CAGR 5Y-7.04%5 year compound

📋

Quarterly Performance

YoY Profit Growth-36.25%

🔴 Significant decline

YoY Sales Growth-19.95%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

1.46%

EPS Growth 5Y

-10.55%

Interest Coverage

Higher = safer debt servicing

2.49

ROE

2.96%

ROCE

6.38%

💡

Growth Analysis

Aarey Drugs & Pharmaceuticals Ltd reported YoY profit growth of -36.25% and revenue growth of -19.95% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 9.76% and profits at -7.04% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Aarey Drugs & Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.